Hong Kong Pharma Digital Technology Holdings Limited
HKPD
$1.35
-$0.09-6.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -4.72% | -4.72% | 58.24% | 58.24% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -4.72% | -4.72% | 58.24% | 58.24% | |
| Cost of Revenue | 16.85% | 16.85% | 61.91% | 61.91% | |
| Gross Profit | -77.07% | -77.07% | 42.63% | 42.63% | |
| SG&A Expenses | 49.21% | 49.21% | -11.42% | -11.42% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | 800.00% | 800.00% | -144.44% | -144.44% | |
| Total Operating Expenses | 20.45% | 20.45% | 50.92% | 50.92% | |
| Operating Income | -162.81% | -162.81% | 202.06% | 202.06% | |
| Income Before Tax | -175.32% | -175.32% | 256.97% | 256.97% | |
| Income Tax Expenses | -150.93% | -150.93% | 496.83% | 496.83% | |
| Earnings from Continuing Operations | -179.18% | -179.18% | 232.77% | 232.77% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -179.18% | -179.18% | 232.77% | 232.77% | |
| EBIT | -162.81% | -162.81% | 202.06% | 202.06% | |
| EBITDA | -158.26% | -158.26% | 185.55% | 185.55% | |
| EPS Basic | -176.11% | -325.82% | 127.47% | 127.47% | |
| Normalized Basic EPS | -168.54% | -- | 144.80% | 144.80% | |
| EPS Diluted | -176.48% | -329.44% | 130.00% | 130.00% | |
| Normalized Diluted EPS | -168.54% | -- | 144.80% | 144.80% | |
| Average Basic Shares Outstanding | 4.11% | -- | 46.13% | 46.13% | |
| Average Diluted Shares Outstanding | 4.11% | 52.14% | 46.13% | 46.13% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |